A new review observes that polyphenols influence the gut microbiota by shifting populations to beneficial strains, thereby influencing the microbial metabolites produced and influencing the central nervous system via the gut-brain axis.
Forthcoming European legislation on health claims could pose a
roadblock to rapid market expansion of polyphenols, the plant-based
antioxidants gaining increasing attention for their
disease-fighting actions, warns a new report.